These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10976589)

  • 1. Brain uptake and the analgesic effect of oxytocin--its usefulness as an analgesic agent.
    Kang YS; Park JH
    Arch Pharm Res; 2000 Aug; 23(4):391-5. PubMed ID: 10976589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability of a capsaicin derivative, [14C]DA-5018 to blood-brain barrier corrected with HPLC method.
    Kang YS; Kim JM
    Arch Pharm Res; 1999 Apr; 22(2):165-72. PubMed ID: 10230507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of [3H]leucine across the blood-brain barrier at high blood-side oxytocin concentrations in normal and morphine-dependent rats.
    Rühle HJ; Russell JA; Ermisch A; Landgraf R
    Neuropeptides; 1992 Jun; 22(2):117-24. PubMed ID: 1407409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal effects of oxytocin and vasopressin receptor agonists on spinal pain processing in male rats.
    Juif PE; Poisbeau P
    Pain; 2013 Aug; 154(8):1449-56. PubMed ID: 23707282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of oxytocin in rats acutely decreases deprivation-induced chow intake, but it fails to affect consumption of palatable solutions.
    Klockars A; Brunton C; Li L; Levine AS; Olszewski PK
    Peptides; 2017 Jul; 93():13-19. PubMed ID: 28460894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
    Gao L; Yu LC
    Regul Pept; 2004 Aug; 120(1-3):53-8. PubMed ID: 15177920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception.
    Hau VS; Huber JD; Campos CR; Davis RT; Davis TP
    Brain Res; 2004 Aug; 1018(2):257-64. PubMed ID: 15276886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacologic properties of antiuterotonic oxytocin analogs in the rat.
    Lundin S; Broeders A; Ohlin M; Hansson K; Bengtsson HI; Trojnar J; Melin P
    J Pharmacol Exp Ther; 1993 Feb; 264(2):783-8. PubMed ID: 8437126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats.
    Gu XL; Yu LC
    J Pain; 2007 Jan; 8(1):85-90. PubMed ID: 17097925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat.
    Bickel U; Schumacher OP; Kang YS; Voigt K
    J Pharmacol Exp Ther; 1996 Jul; 278(1):107-13. PubMed ID: 8764341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue.
    Samii A; Bickel U; Stroth U; Pardridge WM
    Am J Physiol; 1994 Jul; 267(1 Pt 1):E124-31. PubMed ID: 8048500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing.
    Modi ME; Majchrzak MJ; Fonseca KR; Doran A; Osgood S; Vanase-Frawley M; Feyfant E; McInnes H; Darvari R; Buhl DL; Kablaoui NM
    J Pharmacol Exp Ther; 2016 Aug; 358(2):164-72. PubMed ID: 27217590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide oxytocin enhances μ opioid receptor signaling as a positive allosteric modulator.
    Meguro Y; Miyano K; Hirayama S; Yoshida Y; Ishibashi N; Ogino T; Fujii Y; Manabe S; Eto M; Nonaka M; Fujii H; Ueta Y; Narita M; Sata N; Yada T; Uezono Y
    J Pharmacol Sci; 2018 May; 137(1):67-75. PubMed ID: 29716811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin and Pain Perception: From Animal Models to Human Research.
    Boll S; Almeida de Minas AC; Raftogianni A; Herpertz SC; Grinevich V
    Neuroscience; 2018 Sep; 387():149-161. PubMed ID: 28965836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central oxytocin receptor stimulation attenuates the orexigenic effects of butorphanol tartrate.
    Olszewski PK; Klockars OA; Klockars A; Levine AS
    Neuroreport; 2016 Sep; 27(14):1012-7. PubMed ID: 27471903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin inhibited stress induced visceral hypersensitivity, enteric glial cells activation, and release of proinflammatory cytokines in maternal separated rats.
    Xu S; Qin B; Shi A; Zhao J; Guo X; Dong L
    Eur J Pharmacol; 2018 Jan; 818():578-584. PubMed ID: 29162434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
    Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
    Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
    Ring RH; Schechter LE; Leonard SK; Dwyer JM; Platt BJ; Graf R; Grauer S; Pulicicchio C; Resnick L; Rahman Z; Sukoff Rizzo SJ; Luo B; Beyer CE; Logue SF; Marquis KL; Hughes ZA; Rosenzweig-Lipson S
    Neuropharmacology; 2010 Jan; 58(1):69-77. PubMed ID: 19615387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central oxytocin mediates inhibition of sodium appetite by naloxone in hypovolemic rats.
    Blackburn RE; Stricker EM; Verbalis JG
    Neuroendocrinology; 1992 Aug; 56(2):255-63. PubMed ID: 1407380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.